Nearly three million adults in England have still not come forward for a Covid vaccine, data reveals. Experts say the figure includes some people who could get extremely sick if they were to catch ...
based vaccine specialist. For SK Bioscience, the investment is slated to boost its vaccine R&D capabilities, the company said, which currently includes manufacturing of pneumococcal and typhoid ...
The MACH-1 platform is a high-performance microparticle 'gene gun' technology that efficiently and uniquely delivers DNA or RNA vaccine-coated microparticles directly into cells in the epidermis ...
This vaccine is intended to provide better protection against disease even in years when predicted vs. actual circulating strains are highly mismatched. The award includes $300,000 for Phase 1 ...